A study published in the April edition of the Journal of Hospital Medicine combines the principles of real-time feedback and financial incentives to get frontline buy-in for quality improvement initiatives.
In the months following the carbapenem-resistant enterobacteriaceae outbreak linked to duodenoscopes, medical device manufacturer Olympus has repeatedly come under fire for its response to the outbreak.